AstraZeneca

182 results

Traders  on the floor of the NYSE on Monday, November 20th. Photograph: Michael Nagle/Bloomberg

European markets shrugged off the failure of politicians to form a coalition to run Germany, the region’s biggest economy, and gained ground on Monday(...)

The New York Stock Exchange: Switch  jumped by almost half in its trading debut after raising $531m in an initial public offering, the third-biggest technology IPO this year in the US. Photograph: Michael Nagle/Bloomberg

European shares rose for the fourth consecutive week on Friday as confidence over the region’s economic recovery outweighed worries over the Catalonia(...)

British prime minister Theresa May  delivers a speech in Florence on Friday aimed at unlocking Brexit talks. Sterling fell following her comments while Irish stocks exposed to the UK also suffered. Photograph: Maurizio Degl’Innocenti/AFP/Getty Images

Ireland’s Iseq index stood out as a weak spot across European markets on Friday, as Brexit-sensitive stocks such as Bank of Ireland, C&C and Origi(...)

Terry McWade, chief executive of Valitacell. Photograph: Conor McCabe

The breast cancer drug Herceptin and the rheumatoid arthritis drug Humira are breakthrough treatments in their respective areas. Both are also biologi(...)

Traders work on the floor of the New York Stock Exchange on September 11th. Photograph: Michael Nagle/Bloomberg

European shares closed higher on Monday as insurers benefitted from a drop in the estimated cost of Hurricane Irma and investors were relieved that No(...)

Cala Medical founders, from left: Todd Kagawa, Brian Noonan and Jakki Cooney

Sepsis is a serious bloodstream infection. It kills more people than breast cancer, lung cancer and prostate cancer combined. It affects around 26 mil(...)

Iseq heavyweight CRH ending Wednesday 1% lower at €29.16. Its stock has been weak since late May when it was trading at €34.86

Media stocks weighed on European markets on Wednesday, led lower by sharp declines in advertising giant WPP after it cut sales forecasts on weakening (...)

The parent company of Aer Lingus, ICAG, dropped by 0.6 per cent. Photograph: Cyril Byrne

It was a quiet day both in Dublin and across Europe as we came to the end of the summer’s busiest earnings week. Despite thin volumes across the board(...)

Drop in AstraZeneca shares followed a lung cancer drug study failure

The biggest one-day drop in AstraZeneca shares following a drug study failure dominated stock trading in Europe on Thursday, outweighing a handful of (...)

Workers at  AstraZeneca’s  Macclesfield site in England.  Shares in the British drug giant suffered their largest ever fall as it announced a big setback, with a much-awaited trial of a new lung cancer drug failing to show the benefits for which the company had hoped. Photograph: Phil Noble/Reuters

Shares in AstraZeneca were on track to suffer their worst ever fall after the Anglo-Swedish pharmaceutical company suffered a big setback with a much-(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »